Full Text View
Tabular View
No Study Results Posted
Related Studies
Repinotan in Patients With Acute Ischemic Stroke
This study has been completed.
Study NCT00044915   Information provided by Bayer
First Received: September 6, 2002   Last Updated: June 9, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Stroke
Acute Ischemic Stroke
Additional conditions recognized in this trial
Cerebral Infarction
Ischemia
More general conditions related to this trial
Brain Diseases
Brain Infarction
Brain Ischemia
Cardiovascular Diseases
Central Nervous System Diseases
Cerebrovascular Disorders
Nervous System Diseases
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
Repinotan HCl (BAYX3702)
Placebo
Sponsors listed in this trial
Bayer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services